A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT04670679 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04670679
- Sponsor
- Erasca, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2026-02-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.